Trade CSBR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Champions Oncology, Inc. (CSBR) is trading at US$5.22, down 1.14% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$68.91M. Over the past 52 weeks, CSBR has traded between US$4.83 and US$8.74. On Syfe you can trade CSBR with $0 commission and add it to your watchlist.
| Previous close | US$5.28 |
|---|---|
| Market cap | US$68.91M |
| 52-week range | US$4.83 – US$8.74 |
| Volume | 10.92K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Champions Oncology, Inc.
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Year: 1994
Champions Oncology, Inc. (CSBR) stock is trading at US$5.22, -1.14% from the previous close of US$5.28.
The market cap for Champions Oncology, Inc. (CSBR) stock is approximately US$68.91M.
The 52-week high for Champions Oncology, Inc. (CSBR) stock is US$8.74.
The 52-week low for Champions Oncology, Inc. (CSBR) stock is US$4.83.
Champions Oncology, Inc. (CSBR) does not currently pay a dividend.
Stay on top of CSBR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
